191 related articles for article (PubMed ID: 23512566)
1. Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study.
Querol L; Rojas-Garcia R; Casasnovas C; Sedano MJ; Muñoz-Blanco JL; Alberti MA; Paradas C; Sevilla T; Pardo J; Capablo JL; Sivera R; Guerrero A; Gutierrez-Rivas E; Illa I
Muscle Nerve; 2013 Dec; 48(6):870-6. PubMed ID: 23512566
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
Lin CS; Krishnan AV; Park SB; Kiernan MC
Arch Neurol; 2011 Jul; 68(7):862-9. PubMed ID: 21747028
[TBL] [Abstract][Full Text] [Related]
4. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Lopate G; Pestronk A; Al-Lozi M
Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
[TBL] [Abstract][Full Text] [Related]
6. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
7. Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.
Chin RL; Deng C; Bril V; Hartung HP; Merkies IS; Donofrio PD; Van Doorn PA; Dalakas MC; Latov N
Muscle Nerve; 2015 Oct; 52(4):498-502. PubMed ID: 25728021
[TBL] [Abstract][Full Text] [Related]
8. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
10. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
12. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Cocito D; Paolasso I; Antonini G; Benedetti L; Briani C; Comi C; Fazio R; Jann S; Matà S; Mazzeo A; Sabatelli M; Nobile-Orazio E;
Eur J Neurol; 2010 Feb; 17(2):289-94. PubMed ID: 19863650
[TBL] [Abstract][Full Text] [Related]
13. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
[TBL] [Abstract][Full Text] [Related]
14. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
Vina ER; Fang AJ; Wallace DJ; Weisman MH
Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
[TBL] [Abstract][Full Text] [Related]
16. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
Caro XJ; Winter EF; Dumas AJ
Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.
Hughes RA; Donofrio P; Bril V; Dalakas MC; Deng C; Hanna K; Hartung HP; Latov N; Merkies IS; van Doorn PA;
Lancet Neurol; 2008 Feb; 7(2):136-44. PubMed ID: 18178525
[TBL] [Abstract][Full Text] [Related]
18. Pediatric CIDP: Clinical Features and Response to Treatment.
Harada Y; Herrmann DN; Logigian EL
J Clin Neuromuscul Dis; 2017 Dec; 19(2):57-65. PubMed ID: 29189550
[TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment.
Galldiks N; Burghaus L; Dohmen C; Teschner S; Pollok M; Leebmann J; Frischmuth N; Hollinger P; Nazli N; Fassbender C; Klingel R; Benzing T; Fink GR; Haupt WF
Eur Neurol; 2011; 66(4):183-9. PubMed ID: 21912134
[TBL] [Abstract][Full Text] [Related]
20. Motor-dominant chronic inflammatory demyelinating polyneuropathy.
Kimura A; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Yoshino H; Yuasa T; Inuzuka T
J Neurol; 2010 Apr; 257(4):621-9. PubMed ID: 20361294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
